FDA — authorised 22 February 1980
- Marketing authorisation holder: ARMOUR PHARM
- Status: approved
FDA authorised Galzin on 22 February 1980
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 February 1980; FDA authorised it on 28 January 1997.
ARMOUR PHARM holds the US marketing authorisation.